Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Protein tyrosine kinase inhibitors from Kyowa Hakko

Jan. 16, 1997

Tokyo Tanabe discloses beta3-adrenoceptor agonists

Jan. 16, 1997

Searle describes antiinflammatory oxazoles

Jan. 15, 1997

New COX-2 inhibitor series reported by Merck Frosst

Jan. 15, 1997

New PDE IV/TNF inhibitors from Chiroscience

Jan. 15, 1997

PDE IV inhibitors revealed by Byk Gulden

Jan. 15, 1997

New MDR modulators disclosed by Vertex

Jan. 15, 1997

New antimigraine agent from Pfizer

Jan. 15, 1997

Potent antitumor agents described by Daiichi

Jan. 15, 1997

Antifungal agent described by Roussel Morishita

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...